This article was written by Follow Monte Independent Investment Research: Michael Del Monte is a buy-side equity analyst with over 5 years…
Stay informed with free updates Simply sign up to the EU business regulation myFT Digest — delivered directly to your inbox. The…
CVS Health Vs. UnitedHealth: Companies In Crises - Back United's Recovery (UNH)
By Press Room
1 Mins read
This article was written by Follow Edmund Ingham is a biotech consultant. He has been covering biotech, healthcare, and pharma for over…
Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Iran has…
This article was written by Follow Hi, I’m a dedicated Stock Analyst aiming to identify clear winners in the market. I’m here…
This article was written by Follow The Valkyrie Trading Society is a team of analysts sharing high conviction and obscure developed market…
Beam Therapeutics Inc. (BEAM) Presents at Wells Fargo 20th Annual Healthcare Conference
By Press Room
1 Mins read
Follow Play Earnings CallPlay Earnings Call Beam Therapeutics Inc. (NASDAQ:BEAM) Wells Fargo 20th Annual Healthcare Conference 2025 September 4, 2025 1:30 PM…
BABX Could Be A Good Tactical Investment But Beware Of The Risks (NASDAQ:BABX)
By Press Room
1 Mins read
This article was written by Follow I am a young individual investor specializing in finding and analyzing deep value and growth opportunities….
S&P Global: I’m Adding The Newest Dividend King To My Roth IRA (NYSE:SPGI)
By Press Room
1 Mins read
This article was written by Follow My name is Jim Barista, and I am a 30-year-old investor based in the Chicagoland area….
This article was written by Follow Freelance Financial Writer | Investments | Markets | Personal Finance | RetirementI create written content used…